Verrica Pharmaceuticals I... (VRCA)
undefined
undefined%
At close: undefined
0.75
-0.62%
After-hours Dec 13, 2024, 06:54 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income -67.00M -24.49M -35.08M -42.69M -28.21M -20.65M -4.46M -1.91M
Depreciation & Amortization 836.00K 718.00K 472.00K 229.00K 257.00K 20.00K - -
Stock-Based Compensation 14.38M 4.99M 6.05M 9.82M 3.33M 2.25M 82.00K 9.00K
Other Working Capital 11.59M -1.46M -1.03M 2.47M -1.95M 145.00K -270.00K 222.00K
Other Non-Cash Items 3.35M 1.93M 1.44M 940.00K -1.06M -435.00K 18.00K -62.00K
Deferred Income Tax - - 66.00K -138.00K - - - -
Change in Working Capital 9.86M -1.80M -535.00K 1.64M -1.73M 938.00K -206.00K 293.00K
Operating Cash Flow -38.58M -18.65M -27.58M -30.21M -27.41M -17.87M -4.58M -1.61M
Capital Expenditures -362.00K -302.00K -883.00K -1.47M -682.00K -774.00K - -
Acquisitions - - - - - - - -
Purchase of Investments - -4.49M -68.91M -71.74M -89.85M -79.12M - -
Sales Maturities Of Investments - 59.01M 69.00M 69.85M 117.72M - - -
Other Investing Acitivies - -180.00K -201.00K -221.00K -1.22M -499.00K - -
Investing Cash Flow -362.00K 54.04M -998.00K -3.58M 25.95M -79.89M - -
Debt Repayment 44.08M -43.75M 4.97M 34.46M - - - -
Common Stock Repurchased - - - - - - - -
Dividend Paid - - - - - - - -
Other Financial Acitivies -169.00K -17.00K 558.00K 772.00K 423.00K 21.00M 12.72M 483.00K
Financial Cash Flow 74.21M -16.87M 33.65M 35.23M 423.00K 99.38M 12.72M 483.00K
Net Cash Flow 35.27M 18.52M 5.07M 1.45M -1.03M 1.61M 8.14M -1.13M
Free Cash Flow -38.94M -18.95M -28.46M -31.68M -28.09M -18.65M -4.58M -1.61M